No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Pak Fah Yeow International Limited, operating with its subsidiaries, specializes in the production, promotion, and distribution of healthcare goods under the Hoe Hin brand. Its market reach spans the People's Republic of China, Hong Kong, Macau, Southeast Asia, North America, the United Kingdom, and other international territories. The company's operations are categorized into three distinct divisions: Healthcare, Property Investments, and Treasury Investments. Among its key offerings are medicated oils, such as white flower embrocation, along with various ointments and solutions for strain relief, including the floral-scented Fúzai 239 white flower embrocation. Beyond its primary healthcare focus, the firm also commits capital to diverse real estate assets, encompassing commercial, industrial, residential, and car park properties, and additionally provides advertising agency services. This enterprise, established in 1927, maintains its corporate headquarters in Wan Chai, Hong Kong.
www.pakfahyeow.comNo one on the platform currently holds 0239.HK.
No tracked institution reports a position in 0239.HK as of their last filing.
No one on the platform has traded 0239.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 0239.HKPak Fah Yeow International Limited | $2.46 | +0.20% | $765M | — |
| 0690.HKUni-Bio Science Group Limited | $0.07 | -2.67% | $436M | — |
| 0950.HKLee's Pharmaceutical Holdings Limited | $1.15 | +0.44% | $677M | — |
| 1011.HKChina NT Pharma Group Company Limited | $0.36 | +0.00% | $236M | — |
| 1652.HKFusen Pharmaceutical Company Limited | $0.85 | +6.25% | $628M | — |
| 2120.HKWenzhou Kangning Hospital Co., Ltd. | $9.30 | -5.97% | $655M | — |
| 2563.HKBeijing Biostar Pharms Co Ltd | $4.10 | -4.65% | $991M | — |
Source: Financial Modeling Prep · peers by sector/industry